2021 | Paediatric palliative screening scale as a useful tool for clinicians' assessment of palliative care needs of pediatric patients: a retrospective cohort study
| BMC PALLIATIVE CARE |
2015 | Pathologic Outcomes in Men with Low-risk Prostate Cancer Who Are Potential Candidates for Contemporary, Active Surveillance Protocols.
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2022 | Performance of clinician prediction of survival in oncology outpatients with advanced cancer
| PLOS ONE |
2022 | Performance of mid-upper arm circumference and other prognostic indices based on inflammation and nutrition in oncology outpatients: a tertiary cancer center study
| ANNALS OF PALLIATIVE MEDICINE |
2022 | Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up study | CLINICAL ORAL INVESTIGATIONS |
2009 | Permanent pacemaker for syncope after heart transplantation with bicaval technique
| YONSEI MEDICAL JOURNAL |
2019 | PET imaging of HER2 expression with an 18F-fluoride labeled aptamer
| PLOS ONE |
2020 | Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
| Translational and Clinical Pharmacology |
2023 | Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects | Expert Opinion on Drug Metabolism & Toxicology |
2017 | Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
| Transl Clin Pharmacol |
2015 | Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects | CLINICAL THERAPEUTICS |
2017 | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
| DRUG DESIGN DEVELOPMENT AND THERAPY |
2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2016 | Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
| DRUG DESIGN DEVELOPMENT AND THERAPY |
2018 | Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans
| Korean J Physiol Pharmacol |
2024 | Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study
| CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY |
2021 | Population Pharmacokinetics of Primaquine in the Korean Population
| PHARMACEUTICS |
2017 | Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
| SCIENTIFIC REPORTS |
2020 | Positivity of Carbapenemase-producing Enterobacteriaceae in Patients Following Exposure within Long-term Care Facilities in Seoul, Korea
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2009 | Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY |